These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613 [TBL] [Abstract][Full Text] [Related]
6. Acute Lipopolysaccharide-Induced Inflammation Lowers IL-2R Signaling and the Proliferative Potential of Regulatory T Cells. Hsiung S; Moro A; Ban Y; Chen X; Savio AS; Hernandez R; Malek TR Immunohorizons; 2020 Dec; 4(12):809-824. PubMed ID: 33334814 [TBL] [Abstract][Full Text] [Related]
7. Curcumin blocks interleukin (IL)-2 signaling in T-lymphocytes by inhibiting IL-2 synthesis, CD25 expression, and IL-2 receptor signaling. Forward NA; Conrad DM; Power Coombs MR; Doucette CD; Furlong SJ; Lin TJ; Hoskin DW Biochem Biophys Res Commun; 2011 Apr; 407(4):801-6. PubMed ID: 21443863 [TBL] [Abstract][Full Text] [Related]
8. Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients. Cerosaletti K; Schneider A; Schwedhelm K; Frank I; Tatum M; Wei S; Whalen E; Greenbaum C; Kita M; Buckner J; Long SA PLoS One; 2013; 8(12):e83811. PubMed ID: 24376757 [TBL] [Abstract][Full Text] [Related]
9. T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients. Parackova Z; Kayserova J; Danova K; Sismova K; Dudkova E; Sumnik Z; Kolouskova S; Lebl J; Stechova K; Sediva A Autoimmunity; 2016 Dec; 49(8):523-531. PubMed ID: 27560779 [TBL] [Abstract][Full Text] [Related]
10. Tuning IL-2 signaling by ADP-ribosylation of CD25. Teege S; Hann A; Miksiewicz M; MacMillan C; Rissiek B; Buck F; Menzel S; Nissen M; Bannas P; Haag F; Boyer O; Seman M; Adriouch S; Koch-Nolte F Sci Rep; 2015 Mar; 5():8959. PubMed ID: 25753532 [TBL] [Abstract][Full Text] [Related]
11. Decreased regulatory function of CD4 Sheikh V; Zamani A; Mahabadi-Ashtiyani E; Tarokhian H; Borzouei S; Alahgholi-Hajibehzad M Scand J Immunol; 2018 Oct; 88(4):e12711. PubMed ID: 30270447 [TBL] [Abstract][Full Text] [Related]
12. A Common Druggable Defect in Regulatory T Cells from Patients with Autoimmunity. Soares L; Yip L; Hurt CR; Fathman G Crit Rev Immunol; 2020; 40(3):185-193. PubMed ID: 33389883 [TBL] [Abstract][Full Text] [Related]
13. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro. Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956 [TBL] [Abstract][Full Text] [Related]
14. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169 [TBL] [Abstract][Full Text] [Related]
15. Impaired activation of STAT5 upon IL-2 stimulation in Tregs and elevated sIL-2R in Sjögren's syndrome. Keindl M; Davies R; Bergum B; Brun JG; Hammenfors D; Jonsson R; Lyssenko V; Appel S Arthritis Res Ther; 2022 May; 24(1):101. PubMed ID: 35526080 [TBL] [Abstract][Full Text] [Related]
16. ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy. Lopes JE; Fisher JL; Flick HL; Wang C; Sun L; Ernstoff MS; Alvarez JC; Losey HC J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32317293 [TBL] [Abstract][Full Text] [Related]
17. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells. Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562 [TBL] [Abstract][Full Text] [Related]
18. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain. Kirken RA; Rui H; Malabarba MG; Howard OM; Kawamura M; O'Shea JJ; Farrar WL Cytokine; 1995 Oct; 7(7):689-700. PubMed ID: 8580378 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25- and CD25high regulatory T cells. Oberg HH; Wesch D; Grüssel S; Rose-John S; Kabelitz D Int Immunol; 2006 Apr; 18(4):555-63. PubMed ID: 16540526 [TBL] [Abstract][Full Text] [Related]
20. Enhanced interaction between SEC2 mutant and TCR Vβ induces MHC II-independent activation of T cells via PKCθ/NF-κB and IL-2R/STAT5 signaling pathways. Fu X; Xu M; Song Y; Li Y; Zhang H; Zhang J; Zhang C J Biol Chem; 2018 Dec; 293(51):19771-19784. PubMed ID: 30352872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]